CVS Health Corp
CVS- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0000064803
In the last 90 days, CVS Health Corp insiders filed 1 open-market purchase and 0 sales; 2,085 institutions reported holding it in 13F filings for Q2 2026, worth $117.5B in total; 3 superinvestors hold it, including Viking Global Investors and Fairfax Financial.
Key figures
- Market capClose on Nov 9, 2026
- $109.1B
- Insider buysLast 90 days, $2.00M in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +218 vs. previous quarter
- 2,085
- 13F valueReported value at the end of Q2 2026
- $117.5B
- Superinvestors holdingAt the end of Q2 2026
- 3
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $402.1B
- +7.8% year over year
- Net income, FY2025
- $1.77B
- −61.7% year over year
- Free cash flow, FY2025
- $7.81B
- +23.4% year over year
- Revenue, Q3 FY2026
- $108.4B
- +5.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 16.2M
- Shares sold short
- Change
- −276.7K
- −1.7% vs. previous
- Days to cover
- 1.57
- At average daily volume
Superinvestors holding CVS, Q2 2026
Go to the superinvestors tab3 superinvestors report holding CVS Health Corp on Form 13F. Percentages are the stock's share of each portfolio.
Viking Global Investors
Andreas Halvorsen
1.1%
CVS Health Corp's share of the portfolio
- Shares
- 3,663,361
- Value
- $379.0M
| Superinvestor | Weight | Value |
|---|---|---|
| Harris Associates (Oakmark) | <0.1% | $34.7M |
Latest insider trades
See all insider tradesOpen-market purchases and sales by CVS Health Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 (view filing)4:41 PM ET | Nov 6 | Same day | Shah Prem SEVP and Group President | PPurchase | +23.9K | $83.90 | +$2.00M | +36.9%88.5K after | |
| May 21, 2026 (view filing) | May 19-21 | 2 days | Robbins LarryDirector | SSale | −3.37M | $94.15 | −$317.5M | −41.1%4.82M after | 7 lots |
| May 21, 2026 (view filing) | May 21 | Same day | Robbins LarryDirector | SSale | −378.0K | $93.31 | −$35.3M | –0 after | Derivative |
| May 11, 2026 (view filing) | May 8 | 3 days | Mandadi TilakEVP, Chief Exp & Tech Officer | SSale | −69.6K | $89.58 | −$6.23M | −87.3%10.1K after | |
| Jan 27, 2026 (view filing) | Jan 23, 2025 | 369 daysLate | Nelson Steven HEVP and President, Aetna | PPurchaseCommon Stock (By Trust) | +24 | $53.70 | +$1.29K | New position24 after | |
| Oct 14, 2025 (view filing) | Sep 9-Oct 23, 2024 | 400 daysLate | Capozzi Heidi BEVP and Chief People Officer | PPurchase | +80 | $57.36 | +$4.59K | +1,600.0%85 after | 3 lots |
| Aug 29, 2025 (view filing) | Aug 20 | 9 daysLate | Finucane Anne A.Director | SSale | −7.50K | $71.02 | −$532.6K | −25.3%22.2K after | |
| Jun 9, 2025 (view filing) | Jun 5 | 4 days | Sansone Guy PDirector | PPurchase | +1.57K | $63.70 | +$100.0K | +15.0%12.0K after | |
| May 6, 2025 (view filing) | May 2-6 | 4 days | Robbins LarryDirector | SSale | −3.75M | $67.66 | −$253.7M | −31.4%8.20M after | 6 lots |
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Clark James DavidSVP, Cont & Chief Acct Officer | SSale | −7.51K | $66.35 | −$498.5K | −47.2%8.39K after |
Top 10 13F holders, Q2 2026
See all 2,085 holdersThe largest institutional positions in CVS Health Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 123,223,409 | $12.7B | 0.19% | −2,696,444−2.1% | Reduced |
| Vanguard Capital Management LLC | 83,315,369 | $8.62B | 0.18% | +665,293+0.8% | Added |
| Capital World Investors | 74,951,955 | $7.75B | 0.92% | −2,296,687−3.0% | Reduced |
| State Street Corp | 60,283,408 | $6.24B | 0.18% | +961,227+1.6% | Added |
| Dodge & Cox | 50,012,765 | $5.17B | 2.71% | −1,767,351−3.4% | Reduced |
| Wellington Management Group LLP | 33,801,113 | $3.50B | 0.60% | +11,233,381+49.8% | Added |
| Geode Capital Management, LLC | 29,899,653 | $3.08B | 0.16% | +440,611+1.5% | Added |
| FMR LLC | 28,920,617 | $2.99B | 0.13% | −2,276,273−7.3% | Reduced |
| Vanguard Portfolio Management LLC | 26,637,259 | $2.76B | 0.12% | +639,911+2.5% | Added |
| Capital Research Global Investors | 24,329,151 | $2.52B | 0.35% | +4,316,819+21.6% | Added |
Holders of 5% or more of CVS
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of CVS Health Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 8.30%105.3M shares | +1.20 ppfrom 7.10% | Oct 24, 20243 filings | Jul 16, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 7.51%95.6M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Capital World Investors | 13G | 5.50%68.8M shares | New | May 13, 20251 filing | May 13, 2025 | SEC |
Politician trades
All politician trades in CVS32 members of Congress reported 71 trades in CVS Health Corp since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 5, 2026 |  Tommy Tuberville Senate · AL | Sell (full) | $1K-$15K |
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
| May 15, 2026 |  Dwight Evans House · PA | Sell (partial) | $1K-$15K |
| Feb 15, 2026 |  John Boozman Senate · AR | Buy | $1K-$15K |
| Nov 21, 2025 |  Lisa C. McClain House · MI | Sell | $1K-$15K |
Senate · AL · Aug 5, 2026
Sell (full)$1K-$15K
Senate · OK · Jul 21, 2026
Buy$1K-$15K
House · PA · May 15, 2026
Sell (partial)$1K-$15K
Senate · AR · Feb 15, 2026
Buy$1K-$15K
House · MI · Nov 21, 2025
Sell$1K-$15K